EDITORIAL: New Avenues in Controlling Infectious Diseases

  • Hansraj College University of Delhi
To read the full-text of this research, you can request a copy directly from the authors.

No full-text available

Request Full-text Paper PDF

To read the full-text of this research,
you can request a copy directly from the authors.

... Infectious diseases are caused by pathogenic microorganisms and are one of the major health problems worldwide causing millions of death yearly [1]. Staphylococcus aureus infection occurs in 2% to 5% of surgical patients but may be as high as 20%. ...
Background Infections are one of the leading causes of death worldwide and current available treatment remains unsatisfactory due to rise in the cases of antimicrobial resistance. Thus, there is a need for the development of new drugs with different mechanism of action. However, the development of new antimicrobials agents is a long and expensive process. Hence, most of the pharmaceutical companies are looking forward for repurposing already available drugs against microbial infections. Methodology The data related to SERMs and microbial infection has been extracted from Pub Med (from January 1997 to December 2018). A total of 101 studies have been published from 1997 -2018 regarding SERMs and microbial infections. Results On the basis of inclusion and exclusion criteria, 25 studies have been included for the analysis of level of evidence regarding antimicrobial effects of SERMs. Emerging reports have indicated the antimicrobial property of selective estrogen receptor modulators (SERMs) against normal and resistant strains under in vitro and in vivo conditions against wide variety of microorganisms through different mechanism of action. Conclusion In conclusion, SERMs could be developed as a broad spectrum antimicrobial agent alone or in combination with existing antimicrobial agents.
ResearchGate has not been able to resolve any references for this publication.